The PSRC of the Tehran University of Medical Sciences

The PSRC of the Tehran University of Medical Sciences (TUMS) was established in mid 2003. The PSRC tries to spread interest in research among students, to recruit and support researchers at all academic levels, to conduct both fundamental and applied (practical) researches in different fields of pharmaceutical sciences, and to promote research methods and training. The center's present activity is mainly focused on research in different fields of ...

Read more »

Latest News   Archive

...

نشست صمیمی رئيس دانشگاه با سرآمدان پژوهش و فن‌آوری دانشگاه علوم پزشکی تهران

در جلسه ای که روز دوشنبه 27 آذر 96 و به مناسبت هفته پژوهش در معاونت پژوهشی دانشگاه تشکیل شد، دکتر کریمی با جمعی از سرآمدان پژوهش و فناوری دانشگاه دیدار کرد. در این دیدار، ایشان از دانشگاه به عنوان مغز کشور یاد کرد و اعتماد به اساتید را جزو موارد ضروری دانست.
...

دکتر محمد عبداللهی برگزیده ملی در هجدهمین جشنواره پژوهشی ابوریحان

در هجدهمین جشنواره پژوهشی ابوریحان دانشگاه علوم پزشکی شهید بهشتی که روز یکشنبه، 3 دی ماه با حضور دکتر ملک زاده معاون تحقیقات و فناوری وزیر بهداشت در تالار امام خمینی (ره) دانشگاه علوم پزشکی شهید بهشتی برگزار شد، از دکتر عبداللهی به عنوان برگزیده ملی تقدیر به عمل آمد.
...

Report of PSRC’s International Students on “Three days workshop at the Center for Research and Training in Skin Diseases and Leprosy”

Three days workshop at ‘the Center for Research and Training in Skin Diseases and Leprosy’ on the topic of ‘Randomized Clinical Trial – Good Clinical Practice’.
...

شرکت دانشجویان مرکز در کارگاه بررسی اپی ژنتیک و تغییرهای وراثتی در فنوتیپ (تظاهر ژن ها)

تغییرهای اپی ژنتیک بسیاری وجود دارد که سبب می شوند از روی ژن هایی رونویسی شود یا نشود و به چه مقدار رونویسی شود. نشانگرهای اپی ژنتیک که ژن ها را غیر فعال می کنند عبارتند از افزودن متیل به موقعیت هایی خاص در دم هیستون ها این تغییر شیمیایی را تعدادی آنزیم تغییر دهنده هیستون انجام می دهند و سپس تنظیم گرهای کروماتین آن را شناسایی می کنند.

Journal Clubs

  • ...

    MEMS and BioMEMES for biomedical applications- 2nd session

    On 11th December 2017, in the journal club meeting, the second session on the topic “MEMS and BioMEMES for biomedical applications” was held. The new line based on nanoelectronics, micromachining, and cells has been introduced. These techniques have unique properties to solve EMT and size overlapping. Also, it was discussed how microfluidic system is used to discriminate ECTCs and MCTCs from WBCs in an unprocessed blood sample without the need for any proliferating or labeling.

  • ...

    International frame work for copyright

    25th December 2017, in the journal club meeting, the topic “International frame work for copyright” was discussed. Many international frameworks of copyright law, such as Paris Convention, Berne Convention, WTO, WIPO, UNESCO and TRIPS agreements addressing intellectual property rights of member countries. On the other hand, ...

  • ...

    Recent progress in hormones research

    8th January 2018, in the journal club meeting, the topic “Recent progress in hormones research” was discussed. There are new emerging hormones, which are under clinical trials processes such as Betatrophin, Irisin, and Asprosin. Looking at the advances in biological research and the ongoing debates about public health, it is not too difficult to predict that hormones and hormone receptors will remain an exciting and important field of basic research in the future. Further developments in the science of signaling mechanisms will depend heavily on emerging technologies, such as proteomics and structural biology, while receptor pathology and gene therapy will occupy an important niche in clinical practice and commercial exploitation.

  • ...

    Emerging applications of metabolomics in the drug delivery

    15th January 2018, in the journal club meeting, the topic “Emerging applications of metabolomics in the drug delivery” was discussed. Metabolomics is an emerging 'omics' science involving the comprehensive characterization of metabolites and metabolism in biological systems. Recent advances in metabolomics technologies are leading to a growing number of mainstream biomedical applications. In particular, metabolomics is increasingly being used to diagnose disease, understand disease mechanisms, identify novel drug targets, customize drug treatments and monitor therapeutic outcomes. By focusing on the application of metabolomics towards uncovering the underlying causes of complex diseases (such as atherosclerosis, cancer and diabetes), the growing role of metabolomics in drug discovery and its potential effect on precision medicine.